Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Bronchial carcinoma
ADR ID BADD_A07004
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.19      Respiratory and mediastinal neoplasms malignant and unspecified
16.19.02      Respiratory tract and pleural neoplasms malignant cell type unspecified NEC
16.19.02.004      Bronchial carcinoma
22      Respiratory, thoracic and mediastinal disorders
22.08      Respiratory tract neoplasms
22.08.01      Lower respiratory tract neoplasms
22.08.01.015      Bronchial carcinoma
Description Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA. [MeSH]
MedDRA Code 10006417
MeSH ID D002283
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Bronchial carcinoma | Ca bronchus | Cancer of bronchus | Carcinoma bronchiogenic | Malignant neoplasm of main bronchus | Progression of bronchial carcinoma | Carcinoma, Bronchogenic | Bronchogenic Carcinoma | Bronchogenic Carcinomas | Carcinomas, Bronchogenic | Carcinoma, Bronchial | Bronchial Carcinoma | Bronchial Carcinomas | Carcinomas, Bronchial
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00047Afatinib0.000112%
BADD_D00151Apixaban0.000087%
BADD_D00285Bosentan0.000120%
BADD_D00511Clozapine--
BADD_D00535Crizotinib0.000470%
BADD_D00563Dabigatran0.000367%
BADD_D00800Erlotinib0.000168%
BADD_D01136Imatinib0.000168%
BADD_D01418Methotrexate0.000114%
BADD_D01653Paclitaxel0.000246%
BADD_D02147Telmisartan0.000260%
BADD_D02246Tolvaptan0.000058%
BADD_D02464Fingolimod0.000844%
BADD_D02470Nintedanib0.000336%
The 1th Page    1    Total 1 Pages